Consumer Products & Services
- 979.532
- 0.0000.00%
Paragon 28 Price Target Cut to $12.00/Share From $15.00 by Piper Sandler
Analysts Offer Insights on Healthcare Companies: Paragon 28 (FNA), ADMA Biologics (ADMA) and Veracyte (VCYT)
Buy Rating Affirmed for Paragon 28 Amid Revenue Growth and Positive EBITDA Outlook
Analysts Are Bullish on These Healthcare Stocks: Arrowhead Pharmaceuticals (ARWR), Paragon 28 (FNA)
Paragon 28 Analyst Ratings
Buy Rating Affirmed for Paragon 28 Amid Strong Financial Performance and Strategic Growth
Buy Rating Reaffirmed for Six Flags Following Strong Post-Merger Performance and Synergy Potential
Roth MKM Remains a Hold on Aurora Cannabis (ACB)
Lotus Resources Limited (LOT) Gets a Buy From Petra Capital
Evercore ISI Reaffirms Their Hold Rating on Aurora Innovation (AUR)
Lotus Resources Price Target Raised 8.3% to A$0.65/Share by Bell Potter
Nestle Shares up on Jefferies Upgrade
Buy Rating Affirmed on Day One Biopharmaceuticals Following Ojemda's Successful Launch and Strategic Focus on DAY301 Development
RBC Capital Reaffirms Their Buy Rating on Paragon Banking Group PLC (PAG)
CLSA Downgrades Sime Darby Property to Hold From Outperform; Price Target Is 1.70 Ringgit
Nomura Adjusts Nestlé India's Price Target to INR3,000 From INR2,950, Keeps at Buy
Jefferies Adjusts Nestlé India's Price Target to INR2,450 From INR2,500, Keeps at Hold
Nestlé SA (NSRGF) Receives a Buy From Barclays
J.P. Morgan Reaffirms Their Hold Rating on Nestlé SA (NSRGF)
Keefe, Bruyette & Woods Adjusts Price Target on Sandy Spring Bancorp to $30 From $25, Maintains Market Perform